Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 3—March 2007
Research

Effectiveness of Neuraminidase Inhibitors for Preventing Staff Absenteeism during Pandemic Influenza

Vernon J. Lee*Comments to Author  and Mark I. Chen*

Author affiliations: *Tan Tock Seng Hospital, Singapore;

Main Article

Table 2

Effects of influenza pandemic prevention strategies on healthcare worker absenteeism

Reproductive no. (R0)
Pandemic duration, wk
Peak % absent by strategy
(days with >5% absent)
No action
Treatment only
2 weeks’ prophylaxis
4 weeks’ prophylaxis
6 weeks’ prophylaxis
8 weeks’ prophylaxis
1.5242.8 (0)2.1 (0)2.1 (0)2.1 (0)2.2 (0)2.3 (0)
2156.7 (17.8)5.1 (5.4)5.2 (6.5)5.5 (9.1)5.9 (11))4.6 (0)
2.51210.2 (21.1)7.9 (16)8.1 (16.2)8.8 (16.2)7.2 (10.8)2 (0)
31013 (20.6)10.2 (16.6)10.6 (16.7)11.4 (15)4.7 (0)2.5 (0)
4817.3 (18.7)13.9 (15.7)14.6 (15.4)10.8 (11.1)3.7 (0)3.7 (0)
6622.5 (16.5)18.5 (13.9)19.7 (12.9)5.5 (4.1)5.5 (4.1)5.5 (4.1)
Pandemic similar to 1918 “Spanish flu”*20.2 (28.6)15.1 (18.3)15.8 (17.9)11.6 (13)4.1 (0)4.1 (0)

*R0 =4; mortality rate = 5% (hospitalization set to the ratio of the hospitalization rates to the case-fatality rates in Table 1).

Main Article

Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external